spanky, I cannot imagine FDA allowing armed Bavi- without clinical trials because safe doses must be established, as well as safety of the combination, but an abbreviated PI and PII is conceivable, but probably without precedent. Do I think it will happen and be successful? Yes. Further, from an investment point of view, any "armed-Bavi" being brought into clinical trials would almost certainly be accompanied by an appropriate share price run-up. That DOES have precedence, and would be fully justifiable. Also, I foresee a markedly accelerated FDA clearance process for MABs in the near future. The footwork has already been done.
News 
Market Data 
Discover 
AI
